{
    "nctId": "NCT02818816",
    "officialTitle": "A Prospective Study to Evaluate the Effect of Preoperative Topical Brimonidine Tartrate 0.2% (Allergan, Irvine, CA) on Intraocular Pressure (IOP) of Patients Undergoing Robot-assisted Laparoscopic Prostatectomy (RALP)",
    "inclusionCriteria": "* Males aged 18 years and above\n* Patients with a diagnosis of prostatic carcinoma requiring prostate surgery\n* Must be MALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Patients having had an ophthalmic surgical procedure within 6 months of the beginning of the study.\n* Patients with a diagnosis of glaucoma\n* Any abnormality of the cornea which may prevent reliable applanation tonometry\n* Known allergy/ hypersensitivity reaction to Brimonidine\n* Contra-indication to Brimonidine including patients on monoamine oxidase inhibitors (MOA)\n* Patients unwilling or unable to provide informed consent\n* Patients with anticipated difficult airway management (as this may require medications and/or airway manipulations resulting in increased IOP)"
}